The Innovation from Innsbruck: Plant-based Allergen Recombinantly Produced in Green Alga
biotechnet Switzerland
DOI:
https://doi.org/10.2533/chimia.2016.818Keywords:
Algal-derived edible vaccines, Birch pollen (betula) allergen bet v 1, Chlamydomonas reinhardtii, Non- glycosylated therapeutic proteins, Peanut-induced anaphylaxis, Polymerase chain reaction (pcr), Recombinant allergenAbstract
An innovation in biotechnology: for the first time, researchers from MCI Innsbruck and the University of Salzburg have manufactured and purified a plant-based allergen in a green alga and opened the door to a specific immunotherapy against allergies. Their vision: to replace the unpleasant injection with oral administration, as its production is both simple and cost-effective.
Downloads
Published
2016-11-30
Issue
Section
Columns, Conference Reports
Categories
License
Copyright (c) 2016 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
[1]
E. Heinzelmann, Chimia 2016, 70, 818, DOI: 10.2533/chimia.2016.818.
